• About Us
  • Scientists
  • Future of Science
  • Site Map
  • Search
  • Privacy & Terms
  • Contact Us
Silicon Genomics
  • BioCloud
  • Science Professionals
  • Policy Center
  • Research
  • Personalization
  • Media
  • print
  • mail
  • Silicon Genomics | Home

  • About Us
  • BioCloud
  • Science Professionals
  • The Future of Science
  • Research
  • Policy Center
  • Company History
  • Mission and Values
  • Fact Sheets
  • Contact
Welcome to Silicon Genomics
Tapping the power of scientific discovery and technological innovation to advance the practice of insilico drug discovery.

Silicon Genomics aims to serve the scientific community and society by providing innovative technologies that will aid researchers in transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives.

Learn more About us

BioCloud Insilico Drug Discovery Platform
Accelerating scientific breakthroughs from insilico discovery to the lab through the clinic to the marketplace.

BioCloud is a science-focused technology platform that will dramatically accelerate the discovery of human therapeutics.

The BioCloud Insilico Discovery Optimization Platform is being designed exclusively to leverage the enormous power and potential of Bull's Extreme Factory™ High Performance cloud computing platform.

BioCloud will optimize the entire drug discovery process; from target identification and the early detection of high-risk candidate therapies to insilico forced degradation and dissolution modeling.

Learn more about BioCloud

Drug Discovery in the Cloud
Pioneering the development of novel applications of insilico discovery in the industry's first validated Cloud-based computing architecture.

Research dollars are more scarce and more highly scrutinized than ever. Investors and shareholders are looking for rapid results. The time allotted for identifying and validating potential drug candidates is decreasing which in turn, increases research risk.

As a result, potential drug candidates are being missed and risk profiling is being cut short in the interest of saving costs. Much more comprehensive and accurate rapid assessment tools are needed. Recent high-profile cases of side effects could well have been avoided with the application of insilico modeling techniques.

Silicon Genomics BioCloud will dramatically reduce the cost and risk of traditional drug discovery by providing validated and highly advanced insilico modeling tools.

This allows researchers to focus on the important work of "doing" science and not on building and maintaining a complex and costly high performance computing infrastructure to support drug discovery activities.

Learn more about the Science of BioCloud

 

  • Resources of Interest
  • Science
  • Technology
  • Leadership
  • Search
  • Terms of Use
  • Contact
footer